Gary Pace - Mar 6, 2024 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role
Director
Signature
/s/ Kristen Williams, Attorney-in-Fact
Stock symbol
PCRX
Transactions as of
Mar 6, 2024
Transactions value $
-$3,656,226
Form type
4
Date filed
3/8/2024, 05:33 PM
Previous filing
Dec 19, 2023
Next filing
Jul 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCRX Common Stock Sale -$31.6K -1.07K -0.75% $29.67 140K Mar 6, 2024 Direct
transaction PCRX Common Stock Sale -$871K -28.3K -20.13% $30.81 112K Mar 7, 2024 Direct F1
transaction PCRX Common Stock Sale -$2.75M -90K -80.27% $30.60 22.1K Mar 8, 2024 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.550 to $30.965, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 1 and 2.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.300 to $30.860, inclusive.